Desjardins Global Asset Management’s Eli Lilly LLY Stock Holding History

Desjardins Global Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$4.17M	Sell	7,147 -1,765	-20%	-$1.03M	0.45%	37
2023 Q3	$4.79M	Sell	8,912 -3,026	-25%	-$1.56M	0.52%	34
2023 Q2	$5.6M	Buy	11,938 +934	+8%	+$392K	0.65%	28
2023 Q1	$3.78M	Buy	11,004 +2,026	+23%	+$683K	0.48%	39
2022 Q4	$3.28M	Sell	8,978 -5,150	-36%	-$1.83M	0.52%	29
2022 Q3	$4.57M	Sell	14,128 -426	-3%	-$135K	0.58%	22
2022 Q2	$4.72M	Sell	14,554 -11,840	-45%	-$3.55M	0.62%	27
2022 Q1	$7.56M	Sell	26,394 -3,361	-11%	-$865K	0.66%	26
2021 Q4	$8.22M	Buy	+29,755	New	+$7.54M	0.7%	22

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Desjardins Global Asset Management's LLY Position: Q4 2023 in Review

Desjardins Global Asset Management reduced its Eli Lilly (LLY) stake by 20% in Q4 2023, selling an estimated $1.03M and leaving 7,147 shares worth $4.17M. The position accounts for 0.45% of the portfolio, ranked #37.

Desjardins Global Asset Management first reported a position in LLY in Q4 2021 and has held it in 9 quarters since. The position peaked at $8.22M in Q4 2021. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

Desjardins Global Asset Management held 7,147 shares of Eli Lilly worth $4.17M as of Q4 2023.
Desjardins Global Asset Management sold 1,765 Eli Lilly shares in Q4 2023, an estimated $1.03M.
Eli Lilly made up 0.45% of Desjardins Global Asset Management's portfolio in Q4 2023, its #37 holding.
Desjardins Global Asset Management first reported a position in Eli Lilly in Q4 2021 and has held it in 9 quarters since.
Desjardins Global Asset Management's Eli Lilly position peaked at $8.22M in Q4 2021.
3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.